Asteria Health Recalls Testosterone and Anastrozole Sterile Pellets Due to Metal Particulate Matter

What Happened

F.H. INVESTMENTS, Inc. (dba Asteria Health) has initiated a voluntary recall of specific lots of Testosterone 100mg Anastrozole 4mg sterile pellets. The recall was prompted by the discovery of a foreign substance, identified as the potential presence of metal particulate matter within the product.

Which Products Are Affected

The recall involves 1,464 pellets of Testosterone 100mg Anastrozole 4mg (1 Sterile Pellet). The affected products carry the NDC number 79559-4104-32 and are labeled under Asteria Health, Birmingham, AL.

The following lot numbers and expiration dates are included in this recall:

• Lot#: 254000105, Exp. 05/28/2026
• Lot#: 254000110, Exp. 08/07/2026
• Lot#: 254000112, Exp. 09/26/2026
• Lot#: 254000113, Exp. 09/26/2026

What You Should Do

Consumers and healthcare providers should immediately cease use of the affected lots. The firm has initiated notification via letter. For information regarding returns or further instructions, consumers may contact F.H. INVESTMENTS, Inc. (dba Asteria Health) at 432 Industrial Ln, Birmingham, AL 35211-4465.

Why This Matters

The presence of metal particulate matter in a sterile drug product poses a significant health risk, as foreign substances can lead to adverse reactions or complications at the site of administration. This recall is classified as a Class II event by the FDA.

Source

Information provided by the FDA under Recall Number D-0331-2026.